| DFSTX | ORSAX | DFSTX / ORSAX | |
| Total Expense Ratio | 0.27 | 1.24 | 22% |
| Annual Report Gross Expense Ratio | 0.28 | 1.48 | 19% |
| Fund Existence | 35 years | 3 years | - |
| Gain YTD | 14.553 | 17.534 | 83% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 19.1B | 689M | 2,772% |
| Annual Yield % from dividends | 0.97 | 0.00 | - |
| Returns for 1 year | 14.53 | 16.59 | 88% |
| Returns for 3 years | 52.12 | 57.59 | 91% |
| Returns for 5 years | 34.08 | N/A | - |
| Returns for 10 years | 106.13 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TIGAX | 26.88 | 0.12 | +0.45% |
| Thornburg International Growth A | |||
| JSIGX | 24.11 | 0.05 | +0.21% |
| Jacob Small Cap Growth Institutional | |||
| LMIYX | 29.24 | -0.05 | -0.17% |
| Lord Abbett Micro Cap Growth I | |||
| ETCHX | 49.76 | -0.58 | -1.15% |
| Eventide Healthcare & Life Sciences C | |||
| FBIOX | 28.95 | -0.38 | -1.30% |
| Fidelity Select Biotechnology | |||